4.8 Article

Sel1L-Hrd1 ER-associated degradation maintains β cell identity via TGF-β signaling

Journal

JOURNAL OF CLINICAL INVESTIGATION
Volume 130, Issue 7, Pages 3499-3510

Publisher

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI134874

Keywords

-

Funding

  1. Human Pancreas Analysis Program (HPAP) (National Institute of Diabetes and Digestive and Kidney Diseases [NIDDK]) as part of the Human Islet Research Network (HIRN) [SCR_014393, UC4 DK112217]
  2. NIH NIDDK [P30DK020572]
  3. NIH [1R01CA163910, 1R24DK110973, 1R01DK11174, R01DK110047, R01DK117639]
  4. Juvenile Diabetes Research Foundation [2-SRA-2018-539A-B]
  5. American Diabetes Association (ADA) [1-19-IBS-235]
  6. American Heart Association Scientist Development [17SDG33670192]
  7. Michigan Nutrition Obesity Research Center (MNORC) Pilot/Feasibility grant [P30DK089503]
  8. Training Program in Endocrinology and Metabolism [5T32DK007245]
  9. Pew Latin American Postdoctoral Fellowship
  10. ADA

Ask authors/readers for more resources

beta Cell apoptosis and dedifferentiation are 2 hotly debated mechanisms underlying beta cell loss in type 2 diabetes; however, the molecular drivers underlying such events remain largely unclear. Here, we performed a side-by-side comparison of mice carrying beta cell-specific deletion of ER-associated degradation (ERAD) and autophagy. We reported that, while autophagy was necessary for II cell survival, the highly conserved Sel1L-Hrd1 ERAD protein complex was required for the maintenance of beta cell maturation and identity. Using single-cell RNA-Seq, we demonstrated that Sel1L deficiency was not associated with beta cell loss, but rather loss of beta cell identity. Sel1L-Hrd1ERAD controlled II cell identity via TGF-beta signaling, in part by mediating the degradation of TGF-beta receptor 1. Inhibition of TGF-beta signaling in Sel1L-deficient beta cells augmented the expression of II cell maturation markers and increased the total insulin content. Our data revealed distinct pathogenic effects of 2 major proteolytic pathways in beta cells, providing a framework for therapies targeting distinct mechanisms of protein quality control.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available